Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001000731 | SCV001157777 | pathogenic | not specified | 2018-09-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001781258 | SCV002023655 | likely pathogenic | not provided | 2022-12-09 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001781258 | SCV004224605 | likely pathogenic | not provided | 2023-01-19 | criteria provided, single submitter | clinical testing | PP1, PP5, PM2, PS4_moderate, PVS1_moderate |
OMIM | RCV000013693 | SCV000033940 | pathogenic | Hereditary spherocytosis type 2 | 1998-01-01 | no assertion criteria provided | literature only |